This Government Contract opportunity from Department Of Defense was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Supply of Benzonatate Capsules (100 mg)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract seeks the supply and delivery of 100 mg Benzonatate capsules packaged in bottles of 100 units, with all products required to meet stringent federal and military standards for packaging, labeling, and shelf-life compliance. The item is intended for procurement through a subcontract under the Medical Supply Chain Pharm FSA, a component of the Department of Defense, ensuring the medication aligns with readiness and logistical requirements for military healthcare systems. The solicitation was posted on July 16, 2026, with responses due by July 22, 2026, and the NAICS code 325412 indicates the primary industry classification as pharmaceutical and biological product manufacturing. All deliveries must fulfill exact specifications to ensure compatibility with defense medical inventory and distribution protocols.
General Info
Agency
NAICS
Place of Performance
USASet-Aside
Documents
This scope was carved out of SPE2DP-26-T-4186.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
BENZONATATE CAPSULES
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
